Showing results (1281-1290 of 1,357) with videos related to

Sort By:
Pageof 136
The Lancet. Oncology|April 2, 2021
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trialAngela Lamarca, Daniel H Palmer, Harpreet Singh Wasan, et al.
Chembiochem : a European Journal of Chemical Biology|April 10, 2021
Targeted Degradation of PARP14 Using a Heterobifunctional Small MoleculeTim J Wigle, Yue Ren, Jennifer R Molina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These DrugsGwynn Ison, Julia A Beaver, W David McGuinn, et al.
Rheumatology (Oxford, England)|January 13, 2023
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)Deborah J Griffiths-Jones, Yvonne Sylvestre Garcia, W David Ryder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT InvestigatorsTomasz M Beer, Christopher W Ryan, Peter M Venner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutationGeoffrey Kim, Amy E McKee, Yang-Min Ning, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Genetic variants linked to education predict longevityRiccardo E Marioni, Stuart J Ritchie, Peter K Joshi, et al.
The Journal of Clinical Investigation|May 3, 2017
Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunctionChrista F Gaskill, Erica J Carrier, Jonathan A Kropski, et al.
The New England Journal of Medicine|February 18, 2026
An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1Nicholas E Johnson, Li-Jung Tai, Johanna I Hamel, et al.
JAMA Psychiatry|July 27, 2017
Identification of Genetic Loci Jointly Influencing Schizophrenia Risk and the Cognitive Traits of Verbal-Numerical Reasoning, Reaction Time, and General Cognitive FunctionOlav B Smeland, Oleksandr Frei, Karolina Kauppi, et al.
Pageof 136